RSNA 2016

Abstract Archives of the RSNA, 2016


PH005-EB-X

Biomarkers in Molecular Imaging: Intrinsic Prognostic Markers in Monitoring Breast Cancer

All Day Room: PH Community, Learning Center



Shwayta Kukreti, MD, PhD, Los Angeles, CA (Presenter) Nothing to Disclose
Albert Cerussi, PhD, Irvine, CA (Abstract Co-Author) Nothing to Disclose
Bruce Tromberg, MD, Irvine, CA (Abstract Co-Author) Nothing to Disclose
Enrico Gratton, PhD, Irvine, CA (Abstract Co-Author) Nothing to Disclose
TEACHING POINTS

The purpose of this exhibit is to
1. Review molecular in vivo methods2. Review Specific Tumor Component marker of spectroscopy: physics of signal development, biochemical explanations, application in breast imaging3. Review spectral methods in monitoring neoadjuvant chemotherapy: generation of scatter-corrected absorption spectrum, the wavelength dependent changes during chemotherapy, implications for prognosis 

TABLE OF CONTENTS/OUTLINE

The purpose of this exhibit is to1. Review molecular in vivo methods: focus on absorption spectroscopy, fundamentals of light, derivation of tissue characterization, patterns of functional changes in normal/disease states2. Review the Specific Tumor Component-Explain mathematics for quantification of the Specific Tumor Component marker-Demonstrate selection of the wavelength regions-Review the index signal for normal/cancerous tissues-Describe clinical implications of quantification of functional changes3. Review spectral methods in monitoring neoadjuvant chemotherapy: -Show scatter corrected absorption spectrum-Demonstrate main points of  wavelength specific spectral variation-Explain clinical correlation of tissue absorber during neoadjuvant chemotherapy-Describe clinical utility for prognosis4. Summary5. Future directions of molecular imaging in breast cancer